Tacrolimus dose and blood concentration variability in kidney transplant recipients undergoing conversion from twice daily to once daily modified release tacrolimus.

[1]  D. Abramowicz,et al.  Conversion From Prograf to Advagraf Among Kidney Transplant Recipients Results in Sustained Decrease in Tacrolimus Exposure , 2011, Transplantation.

[2]  P. Berloco,et al.  Improvement of graft function after conversion to once daily tacrolimus of stable kidney transplant patients. , 2010, Transplantation proceedings.

[3]  P. Berloco,et al.  Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. , 2010, Transplantation proceedings.

[4]  M. Merli,et al.  Conversion from twice-daily to once-daily tacrolimus administration in liver transplant patient. , 2010, Transplantation proceedings.

[5]  G. Opelz,et al.  Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation , 2009, Transplantation.

[6]  A. Matas,et al.  Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. , 2007, Transplantation.

[7]  A. Israni,et al.  Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. , 2005, Journal of the American Society of Nephrology : JASN.

[8]  J. Schold,et al.  Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[10]  S. Geest,et al.  INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTS , 1995, Transplantation.